Vertex Pharmaceuticals Inc / Ma

VOLORIDGE INVESTMENT MANAGEMENT, LLC VRTX

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/14/2025

Shares

105,502

Value ($000)

41,319

Weight

0.1%

2019 Q4 - 2025 Q3 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/14/2025	41,319	0.1%	105,502	9/30/2025
2024 Q4	2/14/2025	28,073	0.1%	69,712	12/31/2024
2024 Q3	11/14/2024	63,757	0.2%	137,088	9/30/2024
2024 Q2	8/14/2024	23,331	0.1%	49,776	6/30/2024
2024 Q1	5/15/2024	42,293	0.2%	101,177	3/31/2024
2023 Q4	2/14/2024	33,101	0.1%	81,350	12/31/2023
2023 Q3	11/14/2023	11,390	0.1%	32,753	9/30/2023
2023 Q2	8/14/2023	4,927	0.0%	14,000	6/30/2023
2022 Q4	2/14/2023	17,584	0.1%	60,891	12/31/2022
2022 Q2	8/15/2022	6,125	0.0%	21,735	6/30/2022
2021 Q4	2/14/2022	30,602	0.2%	139,353	12/31/2021
2021 Q3	11/15/2021	97,388	0.6%	536,896	9/30/2021
2021 Q2	8/16/2021	50,947	0.4%	252,674	6/30/2021
2021 Q1	5/17/2021	44,885	0.3%	208,875	3/31/2021
2020 Q4	2/16/2021	61,634	0.5%	260,785	12/31/2020
2020 Q3	11/16/2020	17,854	0.1%	65,610	9/30/2020
2019 Q4	2/14/2020	21,405	0.4%	97,763	12/31/2019